Immunitybio Gross Profit from 2010 to 2024
IBRX Stock  USD 5.57 0.27 5.09% 
Gross Profit  First Reported 20150630  Previous Quarter 4.5 M  Current Value 3.4 M  Quarterly Volatility 2.4 M 
Check Immunitybio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immunitybio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 M, Interest Expense of 135.7 M or Selling General Administrative of 91.7 M, as well as many indicators such as Price To Sales Ratio of 6.7 K, Dividend Yield of 0.0 or Days Sales Outstanding of 1.8 K. Immunitybio financial statements analysis is a perfect complement when working with Immunitybio Valuation or Volatility modules.
Immunitybio  Gross Profit 
Latest Immunitybio's Gross Profit Growth Pattern
Below is the plot of the Gross Profit of Immunitybio over the last few years. Gross profit is a required income statement account that reflects total revenue of Immunitybio minus its cost of goods sold. It is profit before Immunitybio operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Immunitybio's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immunitybio's overall financial position and show how it may be relating to other accounts over time.
View  Last Reported 240 K  10 Years Trend 

Gross Profit 
Timeline 
Immunitybio Gross Profit Regression Statistics
Arithmetic Mean  (4,645,233)  
Coefficient Of Variation  (180.23)  
Mean Deviation  6,795,111  
Median  47,000  
Standard Deviation  8,371,956  
Sample Variance  70.1T  
Range  24.9M  
RValue  (0.76)  
Mean Square Error  31.9T  
RSquared  0.58  
Significance  0  
Slope  (1,421,688)  
Total Sum of Squares  981.3T 
Immunitybio Gross Profit History
Other Fundumenentals of Immunitybio
Immunitybio Gross Profit component correlations
Click cells to compare fundamentals
About Immunitybio Financial Statements
Immunitybio investors use historical fundamental indicators, such as Immunitybio's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding overtime patterns can help investors decide on longterm investments in Immunitybio. Please read more on our technical analysis and fundamental analysis pages.
Last Reported  Projected for Next Year  
Gross Profit  17.9 M  17 M  
Gross Profit Margin  (28.76)  (27.32) 
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a marketneutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.